Lucky that increases the production of medicine, sodium carbonate
KARACHI: Lucky Core Industries (LCI) is expanding its production lines for pharmaceuticals and sodium carbonate. However, it delayed the launch of the float glass project and the polyester business has slowed down. After attending a corporate briefing held by LCI this week, Topline Research analyst Nasheed Malik said the conglomerate is expected to complete its acquisition of Pfizer in the pharmaceutical sector in two months to October 2024. In addition, it is expected to start commercial production at the under-construction Greenfield veterinary drug manufacturing unit in the next financial year 2025-26 with an estimated investment of Rs.725 crore. The Competition


